Published in N Engl J Med on July 14, 1977
Norovirus gastroenteritis. N Engl J Med (2009) 7.66
Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med (2008) 4.57
Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med (2011) 3.78
Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J Virol (2007) 3.71
Norwalk virus shedding after experimental human infection. Emerg Infect Dis (2008) 3.70
Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol (2003) 3.15
Inactivation of Norwalk virus in drinking water by chlorine. Appl Environ Microbiol (1985) 3.12
Human viral gastroenteritis. Microbiol Rev (1984) 2.70
Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J Virol (2007) 2.68
Cellular and humoral immunity following Snow Mountain virus challenge. J Virol (2005) 2.59
Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J Clin Microbiol (1993) 2.58
Viral shape-shifting: norovirus evasion of the human immune system. Nat Rev Microbiol (2010) 2.53
Attachment and entry of recombinant Norwalk virus capsids to cultured human and animal cell lines. J Virol (1996) 2.51
Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis (2013) 2.50
The isolation and characterization of a Norwalk virus-specific cDNA. J Clin Invest (1991) 2.42
Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis (2010) 2.21
Immune response and prevalence of antibody to Norwalk enteritis virus as determined by radioimmunoassay. J Clin Microbiol (1979) 2.06
Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLoS Pathog (2012) 2.02
Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc Natl Acad Sci U S A (2010) 1.96
A homozygous nonsense mutation (428G-->A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J Virol (2005) 1.93
The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 Norovirus infection. PLoS One (2009) 1.89
Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants. PLoS Pathog (2010) 1.88
Incidence and risk factors for community-acquired acute gastroenteritis in north-west Germany in 2004. Eur J Clin Microbiol Infect Dis (2009) 1.76
Noroviruses: The leading cause of gastroenteritis worldwide. Discov Med (2010) 1.73
Heterotypic humoral and cellular immune responses following Norwalk virus infection. J Virol (2009) 1.70
Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection. PLoS Pathog (2008) 1.69
Antibody is critical for the clearance of murine norovirus infection. J Virol (2008) 1.69
Pathogenesis of noroviruses, emerging RNA viruses. Viruses (2010) 1.67
Norwalk virus RNA is infectious in mammalian cells. J Virol (2007) 1.66
Subclass-specific serum antibody responses to recombinant Norwalk virus capsid antigen (rNV) in adults infected with Norwalk, Snow Mountain, or Hawaii virus. J Clin Microbiol (1993) 1.63
Serial propagation of porcine enteric calicivirus-like virus in primary porcine kidney cell cultures. J Clin Microbiol (1988) 1.57
Burden of norovirus in healthcare facilities and strategies for outbreak control. J Hosp Infect (2015) 1.55
Western blot (immunoblot) assay of small, round-structured virus associated with an acute gastroenteritis outbreak in Tokyo. J Clin Microbiol (1989) 1.55
Prevalence of antibody to the Norwalk virus in various countries. Infect Immun (1979) 1.54
Herd immunity to GII.4 noroviruses is supported by outbreak patient sera. J Virol (2009) 1.51
Advances in norovirus biology. Cell Host Microbe (2014) 1.45
Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med (2014) 1.43
Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability. J Virol (2011) 1.43
Norovirus. Clin Microbiol Rev (2015) 1.41
Norovirus immunity and the great escape. PLoS Pathog (2012) 1.40
Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans. Virology (2010) 1.40
Noroviruses - State of the Art. Food Environ Virol (2010) 1.39
Duration of immunity to norovirus gastroenteritis. Emerg Infect Dis (2013) 1.38
Virus-like particle, 35 to 40 nm, associated with an institutional outbreak of acute gastroenteritis in adults. J Clin Microbiol (1979) 1.35
Detection of immunoglobulin M (IgM), IgA, and IgG Norwalk virus-specific antibodies by indirect enzyme-linked immunosorbent assay with baculovirus-expressed Norwalk virus capsid antigen in adult volunteers challenged with Norwalk virus. J Clin Microbiol (1994) 1.33
Cytokine and antibody responses in gnotobiotic pigs after infection with human norovirus genogroup II.4 (HS66 strain). J Virol (2007) 1.31
Host, weather and virological factors drive norovirus epidemiology: time-series analysis of laboratory surveillance data in England and Wales. PLoS One (2009) 1.30
Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Eur J Pediatr (2013) 1.29
Immunoglobulin M responses to the Norwalk virus of gastroenteritis. Infect Immun (1982) 1.27
The potential economic value of a human norovirus vaccine for the United States. Vaccine (2012) 1.23
Outbreaks of food-borne and waterborne viral gastroenteritis. Clin Microbiol Rev (1993) 1.23
Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg Infect Dis (2013) 1.23
Identification of immune and viral correlates of norovirus protective immunity through comparative study of intra-cluster norovirus strains. PLoS Pathog (2013) 1.22
Human viral gastroenteritis. Clin Microbiol Rev (1989) 1.21
Waterborne gastroenteritis due to the Norwalk agent: clinical and epidemiologic investigation. Am J Public Health (1982) 1.20
Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay. Clin Vaccine Immunol (2011) 1.20
Influence of novel norovirus GII.4 variants on gastroenteritis outbreak dynamics in Alberta and the Northern Territories, Canada between 2000 and 2008. PLoS One (2010) 1.20
Comparative study of the acquisition of antibody to Norwalk virus in pediatric populations. Infect Immun (1980) 1.18
Type I and type II interferons inhibit the translation of murine norovirus proteins. J Virol (2009) 1.18
Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge. J Virol (2009) 1.17
Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane. J Virol (2004) 1.16
Host genetic resistance to symptomatic norovirus (GGII.4) infections in Denmark. J Clin Microbiol (2007) 1.15
Serum immunoglobulin A response to Norwalk virus infection. J Clin Microbiol (1989) 1.11
Diagnostic accuracy and analytical sensitivity of IDEIA Norovirus assay for routine screening of human norovirus. J Clin Microbiol (2010) 1.11
Experimental inoculation of juvenile rhesus macaques with primate enteric caliciviruses. PLoS One (2012) 1.10
Risk factors for winter outbreak of acute diarrhoea in France. Winter outbreaks of diarrhoea occur in United Kingdom too. BMJ (1998) 1.09
Primary high-dose murine norovirus 1 infection fails to protect from secondary challenge with homologous virus. J Virol (2009) 1.06
New real-time PCR detects prolonged norovirus excretion in highly immunosuppressed patients and children. J Clin Microbiol (2009) 1.06
Persistent enteric murine norovirus infection is associated with functionally suboptimal virus-specific CD8 T cell responses. J Virol (2013) 1.05
Norovirus vaccine development: next steps. Expert Rev Vaccines (2012) 1.03
Sequential gastroenteritis episodes caused by 2 norovirus genotypes. Emerg Infect Dis (2014) 1.02
Human norovirus transmission and evolution in a changing world. Nat Rev Microbiol (2016) 1.01
Development of Norwalk virus-specific monoclonal antibodies with therapeutic potential for the treatment of Norwalk virus gastroenteritis. J Virol (2013) 0.99
Continuous presence of noroviruses and sapoviruses in raw sewage reflects infections among inhabitants of Toyama, Japan (2006 to 2008). Appl Environ Microbiol (2009) 0.98
Virus Genotype Distribution and Virus Burden in Children and Adults Hospitalized for Norovirus Gastroenteritis, 2012-2014, Hong Kong. Sci Rep (2015) 0.97
Innate Susceptibility to Norovirus Infections Influenced by FUT2 Genotype in a United States Pediatric Population. Clin Infect Dis (2015) 0.95
Pattern of circulation of norovirus GII strains during natural infection. J Clin Microbiol (2014) 0.93
Identification of cross-reactive norovirus CD4+ T cell epitopes. J Virol (2010) 0.91
Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go? PLoS Pathog (2016) 0.90
Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae. Hum Vaccin Immunother (2015) 0.86
The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control. PLoS Med (2016) 0.86
Identification of a novel cellular target and a co-factor for norovirus infection - B cells & commensal bacteria. Gut Microbes (2015) 0.85
Norovirus immunology: Of mice and mechanisms. Eur J Immunol (2015) 0.85
Comparison of systemic and local immunity in dogs with canine parvovirus gastroenteritis. Infect Immun (1982) 0.85
Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity. Clin Vaccine Immunol (2014) 0.84
Genetic susceptibility to norovirus GII.3 and GII.4 infections in Chinese pediatric diarrheal disease. Pediatr Infect Dis J (2014) 0.84
Multiple viral infections and genomic divergence among noroviruses during an outbreak of acute gastroenteritis. J Clin Microbiol (2006) 0.84
Inhibition of norovirus replication by morpholino oligomers targeting the 5'-end of the genome. Virology (2008) 0.84
Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses. J Virol (2014) 0.83
Norwalk virus: a major cause of epidemic gastroenteritis. Am J Public Health (1982) 0.83
Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs. J Virol (2014) 0.83
Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives. Future Virol (2015) 0.82
Norwalk like viruses: study of an outbreak. Arch Dis Child (1986) 0.82
Innate Resistance and Susceptibility to Norovirus Infection. PLoS Pathog (2016) 0.81
Norovirus mechanisms of immune antagonism. Curr Opin Virol (2015) 0.79
Vaccine against norovirus. Hum Vaccin Immunother (2014) 0.79
Norovirus recognition sites on histo-blood group antigens. Front Microbiol (2012) 0.79
Human norovirus infection and the acute serum cytokine response. Clin Exp Immunol (2015) 0.78
Benign Rabbit Caliciviruses Exhibit Evolutionary Dynamics Similar to Those of Their Virulent Relatives. J Virol (2016) 0.78
Developments in understanding acquired immunity and innate susceptibility to norovirus and rotavirus gastroenteritis in children. Curr Opin Pediatr (2015) 0.77
Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol (1972) 9.12
Enzyme-linked immunosorbent assay (ELISA) for detection of human reovirus-like agent of infantile gastroenteritis. Lancet (1977) 7.84
Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children. N Engl J Med (1976) 7.57
Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc Natl Acad Sci U S A (1966) 7.35
Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis (1984) 7.16
Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology (1981) 6.94
An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol (1969) 6.85
Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52
Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proc Natl Acad Sci U S A (1985) 5.94
Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science (1973) 5.82
Reoviruslike agent in stools: association with infantile diarrhea and development of serologic tests. Science (1974) 5.32
Human rotavirus type 2: cultivation in vitro. Science (1980) 5.22
Definition of human rotavirus serotypes by plaque reduction assay. Infect Immun (1982) 5.19
Enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1977) 5.17
Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. J Clin Microbiol (1983) 4.88
Epidemiology of human rotavirus Types 1 and 2 as studied by enzyme-linked immunosorbent assay. N Engl J Med (1978) 4.73
Rescue of noncultivatable human rotavirus by gene reassortment during mixed infection with ts mutants of a cultivatable bovine rotavirus. Proc Natl Acad Sci U S A (1981) 4.47
Comparison of human and animal rotavirus strains by gel electrophoresis of viral RNA. Virology (1978) 4.08
Solid-phase microtiter radioimmunoassay for detection of the Norwalk strain of acute nonbacterial, epidemic gastroenteritis virus and its antibodies. J Med Virol (1978) 4.06
Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. J Infect Dis (1971) 3.88
Antigenic characterization of human and animal rotaviruses by immune adherence hemagglutination assay (IAHA): evidence for distinctness of IAHA and neutralization antigens. Infect Immun (1981) 3.83
Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med (1997) 3.80
New complement-fixation test for the human reovirus-like agent of infantile gastroenteritis. Nebraska calf diarrhea virus used as antigen. Lancet (1975) 3.56
Viral gastroenteritis. N Engl J Med (1981) 3.51
Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A (1967) 3.47
Serologic evidence for human infection with adenovirus-associated viruses. J Natl Cancer Inst (1968) 3.44
Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh. Lancet (1976) 3.38
Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med (1975) 3.31
Intestinal M cells: a pathway for entry of reovirus into the host. Science (1981) 3.23
Use of transcription probes for genotyping rotavirus reassortants. Virology (1982) 3.23
Comparison of the amino acid sequences of the major neutralization protein of four human rotavirus serotypes. Virology (1987) 3.22
Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol (1988) 3.20
Distinctive ribonucleic acid patterns of human rotavirus subgroups 1 and 2. Infect Immun (1981) 3.13
Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis (1974) 3.10
ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J Infect Dis (1993) 3.06
Comparison of direct electron microscopy, immune electron microscopy, and rotavirus enzyme-linked immunosorbent assay for detection of gastroenteritis viruses in children. J Clin Microbiol (1981) 3.05
Rescue and serotypic characterization of noncultivable human rotavirus by gene reassortment. Infect Immun (1982) 2.97
Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol (1985) 2.95
Biological properties of Norwalk agent of acute infectious nonbacterial gastroenteritis. Proc Soc Exp Biol Med (1972) 2.94
Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4. Proc Natl Acad Sci U S A (1990) 2.90
The changing epidemiology of astrovirus-associated gastroenteritis: a review. Arch Virol Suppl (1996) 2.88
Organ culture of mucosal biopsies of human small intestine. J Clin Invest (1969) 2.87
Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya. N Engl J Med (1978) 2.86
The histologic spectrum of Barrett's esophagus. N Engl J Med (1976) 2.84
Detection of Norwalk virus in stool specimens by reverse transcriptase-polymerase chain reaction and nonradioactive oligoprobes. J Clin Microbiol (1992) 2.77
Antigenic relationships among five reovirus-like (RVL) agents by complement fixation (CF) and development of new substitute CF antigens for the human RVL agent of infantile gastroenteritis. Proc Soc Exp Biol Med (1976) 2.74
Pattern of shedding of the Norwalk particle in stools during experimentally induced gastroenteritis in volunteers as determined by immune electron microscopy. J Infect Dis (1975) 2.74
Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun (1977) 2.72
Human viral gastroenteritis. Microbiol Rev (1984) 2.70
Epidemic gastritis with hypochlorhydria. Gastroenterology (1979) 2.65
Immunological response to infection with human reovirus-like agent: measurement of anti-human reovirus-like agent immunoglobulin G and M levels by the method of enzyme-linked immunosorbent assay. Infect Immun (1978) 2.64
Experimental clindamycin-associated colitis in rabbits. Evidence of toxin-mediated mucosal damage. Gastroenterology (1978) 2.63
Proteins of Norwalk virus. J Virol (1981) 2.59
Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J Clin Microbiol (1993) 2.58
Comparative epidemiology of two rotavirus serotypes and other viral agents associated with pediatric gastroenteritis. Am J Epidemiol (1979) 2.56
Pediatric viral gastroenteritis during eight years of study. J Clin Microbiol (1983) 2.50
Epithelial cell renewal in cultured rectal biopsies in ulcerative colitis. Gastroenterology (1973) 2.48
Serotypic characterization of rotaviruses derived from asymptomatic human neonatal infections. J Clin Microbiol (1985) 2.47
Prediction of human rotavirus serotype by nucleotide sequence analysis of the VP7 protein gene. J Virol (1988) 2.44
Conservation of the fourth gene among rotaviruses recovered from asymptomatic newborn infants and its possible role in attenuation. J Virol (1986) 2.42
Astroviruses as a cause of gastroenteritis in children. N Engl J Med (1991) 2.42
Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis (1975) 2.41
Differentiation of human and calf reoviruslike agents associated with diarrhea using polyacrylamide gel electrophoresis of RNA. Virology (1976) 2.40
Approaches to immunization of infants and young children against gastroenteritis due to rotaviruses. Rev Infect Dis (1980) 2.39
Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus. J Virol (1988) 2.38
Conservation of amino acid sequence of VP8 and cleavage region of 84-kDa outer capsid protein among rotaviruses recovered from asymptomatic neonatal infection. Proc Natl Acad Sci U S A (1986) 2.37
Enzyme-linked immunosorbent assay for identification of rotaviruses from different animal species. Science (1978) 2.36
More on RotaShield and intussusception: the role of age at the time of vaccination. J Infect Dis (2005) 2.32
Role of heat-labile toxigenic Escherichia coli and Reovirus-like agent in diarrhoea in Boston children. Lancet (1975) 2.31
Influence of immunological factors in respiratory syncytial virus disease. Arch Environ Health (1970) 2.30
Detection by immune electron microscopy of 26- to 27-nm viruslike particles associated with two family outbreaks of gastroenteritis. J Infect Dis (1977) 2.25
A microtiter solid phase radioimmunoassay for detection of the human reovirus-like agent in stools. J Immunol (1977) 2.24
Nucleotide sequence of the structural glycoprotein VP7 gene of Nebraska calf diarrhea virus rotavirus: comparison with homologous genes from four strains of human and animal rotaviruses. Virology (1985) 2.23
Epithelial-cell renewal in cultured duodenal biopsies in celiac sprue. N Engl J Med (1970) 2.17
Case-control study of endemic diarrheal disease in Thai children. J Infect Dis (1989) 2.14
Sequential enteric illnesses associated with different rotavirus serotypes. Lancet (1978) 2.13
Temperature-sensitive mutants of influenza A virus. XII. Safety, antigenicity, transmissibility, and efficacy of influenza A/Udorn/72-ts-1[E] recombinant viruses in human adults. J Infect Dis (1976) 2.12
Detection and genotyping of human group A rotaviruses by oligonucleotide microarray hybridization. J Clin Microbiol (2002) 2.12
Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies. J Virol (1988) 2.12
Isolation of adenovirus-associated viruses from man. Proc Natl Acad Sci U S A (1967) 2.10
A collaborative report: rhinoviruses--extension of the numbering system from 89 to 100. Virology (1987) 2.10
Structure, distribution, and origin of M cells in Peyer's patches of mouse ileum. Gastroenterology (1984) 2.10
Immune response and prevalence of antibody to Norwalk enteritis virus as determined by radioimmunoassay. J Clin Microbiol (1979) 2.06
Role of Norwalk virus in outbreaks of nonbacterial gastroenteritis. J Infect Dis (1979) 2.05
The mucosal lesion of the proximal small intestine in acute infectious nonbacterial gastroenteritis. N Engl J Med (1973) 1.98
Epidemiology of adenovirus-associated virus infection in a nursery population. Am J Epidemiol (1968) 1.96
Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen. J Virol (1988) 1.96
Determinants of reovirus interaction with the intestinal M cells and absorptive cells of murine intestine. Gastroenterology (1983) 1.95
Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination. J Infect Dis (1986) 1.95
Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance. J Infect Dis (1983) 1.94
Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology (1985) 1.94
Identification of minireovirus as a Norwalk-like virus in pediatric patients with gastroenteritis. J Virol (1994) 1.93
Measurement of rotavirus antibody by an enzyme-linked immunosorbent assay blocking assay. J Clin Microbiol (1978) 1.93